NCT01252888已完成4 期
A Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two Trabecular Micro-bypass Stents
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 39
- 试验地点
- 2
- 主要终点
- mean diurnal IOP reduction of greater than or equal to 20% at Month 12 vs baseline
研究概览
简要总结
The purpose of this study is to assess efficacy and safety of two iStents for the reduction of intraocular pressure associated with primary open-angle glaucoma.
详细描述
This study evaluates the safety and efficacy of two iStents implanted in primary open-angle glaucoma subjects.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Diagnosed with primary open-angle glaucoma (POAG)
- •Subjects on two topical hypotensive medications
排除标准
- •Traumatic, uveitic, neovascular, or angle closure glaucoma
- •Fellow eye already enrolled
结局指标
主要结局
mean diurnal IOP reduction of greater than or equal to 20% at Month 12 vs baseline
时间窗: 12 months
次要结局
- Mean diurnal IOP < 18 mmHg at month 12(12 months)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStentsSubjects With Primary Open-angle Glaucoma (POAG)NCT01252862Glaukos Corporation40
已完成
4 期
Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive AgentsOpen-angle GlaucomaNCT02873806Glaukos Corporation53
已完成
4 期
Two Second-Generation Trabecular Micro-bypass Stents to Treat Glaucoma Subjects on One Hypotensive MedicationOpen Angle GlaucomaNCT02868190Glaukos Corporation57
已完成
3 期
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionGlaucomaOcular HypertensionNCT00333125Alcon Research319
已完成
4 期
A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal StentSubject With Primary Open-angle Glaucoma (POAG)NCT01252914Glaukos Corporation80
